Anavex Life Sciences (AVXL) Tops Q3 EPS by 3c

Anavex Life Sciences (NASDAQ: AVXL) reported Q3 EPS of ($0.14), $0.03 better than the analyst estimate of ($0.17).

For earnings history and earnings-related data on Anavex Life Sciences (AVXL) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Nvidia pitches Vera CPU to Chinese clients with August delivery target
• UBS Reiterates Neutral Rating on Lennar (LEN) Following Q2 Results